Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000205963 | SCV000261433 | likely benign | Congenital contractural arachnodactyly | 2023-12-09 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000205963 | SCV000452574 | likely benign | Congenital contractural arachnodactyly | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Gene |
RCV000612271 | SCV000729240 | benign | not specified | 2017-09-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001812209 | SCV001471482 | uncertain significance | not provided | 2023-03-06 | criteria provided, single submitter | clinical testing | The FBN2 c.5917+9T>G variant (rs371439173), to our knowledge, has not been reported in the medical literature but is reported in ClinVar (Variation ID: 220686). This variant is found in the general population with an allele frequency in East Asian populations of 0.06% (12/19952 alleles) in the Genome Aggregation Database. This is an intronic variant in a weakly conserved nucleotide, but computational analyses (Alamut v.2.11) predict that this variant may impact splicing by creating a novel cryptic donor splice site, although RNA studies would be required to confirm this. Due to limited information, the clinical significance of the c.5917+9T>G variant is uncertain at this time. |
Prevention |
RCV003927877 | SCV004745646 | likely benign | FBN2-related disorder | 2020-09-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |